A Phase I, Randomized, Double-Blinded, Single-Dose Study Evaluating the Pharmacokinetic Equivalence of the Biosimilar IBI305 and Bevacizumab in Healthy Male Subjects
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS（2019）
关键词
biosimilar,phase I,IBI305,bevacizumab,pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要